Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Gastrointest Endosc ; 39(2): 164-7, 1993.
Article in English | MEDLINE | ID: mdl-8388345

ABSTRACT

Endoscopic stent placement has become accepted palliative therapy for malignant biliary tract obstruction. Because stent occlusion remains a significant late complication, prophylactic replacement has been suggested, although the appropriate time interval remains unclear. Patients with malignant biliary strictures who received 10F or 11.5F stents were analyzed with respect to clinical response, occlusion rates at 3 and 6 months, and survival rates. Seventy stents were placed in 50 patients. Pancreatic carcinoma was the most common underlying malignancy. Overall, obstructive symptoms resolved in 94% of cases. Occlusion rates at 3 months (4.2%) and 6 months (10.8%) were not significantly different. Median overall survival averaged 22 weeks. Results were also stratified by underlying diagnosis, with the worst clinical response and survival being seen in the group of patients with metastatic cancer. Findings suggest that the time interval for stent replacement can be extended safely from 3 to 6 months, resulting in decreased patient discomfort and cost and obviating any replacement in that significant percentage of patients who expire before 6 months.


Subject(s)
Bile Duct Neoplasms/complications , Cholestasis/therapy , Pancreatic Neoplasms/complications , Stents , Adenoma, Bile Duct/complications , Adenoma, Bile Duct/mortality , Adult , Aged , Aged, 80 and over , Bile Duct Neoplasms/mortality , Cholestasis/etiology , Endoscopy, Digestive System , Female , Humans , Male , Middle Aged , Pancreatic Neoplasms/mortality , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...